Navigation Links
New Capillary Column From Varian, Inc. Offers Durability and Performance for High Temperature GC and GC/MS
Date:3/31/2008

PALO ALTO, Calif., March 31 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) announced today the release of the VF-5ht UltiMetal(TM) column for high temperature gas chromatography (GC), which is resistant to damage under extreme operating conditions. These highly durable columns allow chemists to confidently analyze samples at very high temperatures, up to 450 degrees Celsius. Based on a stainless steel capillary, Varian's UltiMetal columns address several problems associated with fused silica columns. A proprietary manufacturing process renders the steel inert and enhances the bonding of the stationary phase. The result is long column lifetime with excellent peak shape and low column bleed for the best detection limits at high temperatures. The UltiMetal column is a high performance, lasting solution for high temperature gas chromatography.

The columns have wide applicability in the separation of high boiling mixtures such as long chain hydrocarbons, polymers, plastics, waxes, heavy polyaromatic hydrocarbons, tars, triglycerides, motor oils, surfactants and crown ethers.

The VF-5ht UltiMetal column is the latest addition to Varian's superb FactorFour range of low bleed GC columns. FactorFour columns offer bleed specifications up to four times better than alternative products. The columns are synthesized using a proprietary stabilization technology that results in high signal-to-noise ratios for trace analysis, lower detector contamination for reduced maintenance, better spectra, fewer background ions and faster stabilization. In short, they provide better chromatography.

"Less column breakage results in savings for laboratories that analyze samples with high temperature GC," says Martin O'Donoghue, Senior Vice President, Scientific Instruments, Varian, Inc. "Higher temperatures are often applied to speed up the analysis of high boiling components and boost productivity. The VF-5ht UltiMetal column is the ideal solution for these applications."

For more technical information about Varian's GC and Mass Spectrometry instrumentation and consumables, please visit http://www.varianinc.com/products/

Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science and industrial applications. The company provides complete solutions, including instruments, vacuum products, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc. employs approximately 3,900 people worldwide and operates manufacturing facilities in North America, Europe and Asia Pacific. Varian, Inc. had fiscal year 2007 sales of $921 million, and its common stock is traded on the NASDAQ Global Select Market under the symbol, "VARI." Further information is available on the company's Web site: http://www.varianinc.com.

For More Information, Contact:

Public Relations

Varian, Inc.

650.424.3845

pr@varianinc.com


'/>"/>
SOURCE Varian, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Supelco(R) Introduces Ascentis(R) Express HILIC HPLC Columns for High-Speed and High-Efficiency Separations
2. New FT-IR Spectrometer Series from Varian, Inc.
3. New Dual Cold Probe From Varian, Inc. Increases Sensitivity and Reduces Analysis Times for 13C NMR Experiments
4. Double Resonance Probe for Liquid State NMR Applications From Varian, Inc. Increases Productivity for Routine Analyses
5. New FTMS System From Varian, Inc. Offers Switchable LC and GC Sources and True Triple Quadrupole Capabilities
6. New Chromatography Detectors From Varian, Inc. Extend the Range of Universal Detection for HPLC and LC/MS
7. Varian, Inc. Reports First Quarter 2008 Results
8. Minimally Invasive Treatment Offers Hope for Liver Cancer Patients
9. Marketing and Meeting Details (M2D) Offers Customized Convention Registration and Management Tool to Clients Inside and Outside of Pharma/Biotech
10. DuPont Chief Science & Technology Officer Offers Perspectives on Science and Global Policymaking at Davos World Economic Forum
11. Woodbridge Offers the Broadest Range of BioFoam(TM) Green Polyurethane Automotive Interior Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... The ... three Winners and six Finalists of the 2017 Blavatnik Regional Awards for Young ... Family Foundation and administered by the New York Academy of Sciences to honor ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... first-ever genomics analysis platform specifically designed for life science researchers to analyze ... pioneering researcher Rosalind Franklin, who made a major contribution to the discovery ...
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ., ... a Webinar titled, “Pathology is going digital. Is your lab ready?” with Dr. ... best practices and how Proscia improves lab economics and realizes an increase in ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
Breaking Biology Technology:
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
(Date:4/5/2017)... , April 5, 2017 Today ... announcing that the server component of the HYPR platform ... for providing the end-to-end security architecture that empowers biometric ... HYPR has already secured over 15 million users ... including manufacturers of connected home product suites and physical ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
Breaking Biology News(10 mins):